Showing results (31-40 of 129) with videos related to

Sort By:
Pageof 13
Journal of Virology|August 29, 2022
Establishment and Characterization of an HBV Viral Spread and Infectious System following Long-Term Passage of an HBV Clinical Isolate in the Primary Human Hepatocyte and Fibroblast Coculture SystemYang Liu, Dmytro Kornyeyev, Lindsey May, et al.
Journal of Virological Methods|September 23, 2015
Development and application of a fast, reproducible assay to measure HCV NS3 protease activity using Escherichia coli lysateBin Han, Hadas Dvory-Sobol, Andrew Greenstein, et al.
Journal of Viral Hepatitis|May 18, 2021
Hepatitis B virus genome diversity in adolescents: Tenofovir disoproxil fumarate treatment effect and HBeAg serocon versionChristophe Combet, Neeru Bhardwaj, Charlotte Hedskog, et al.
Antimicrobial Agents and Chemotherapy|July 24, 2013
Characterization of Hepatitis C virus resistance from a multiple-dose clinical trial of the novel NS5A inhibitor GS-5885Kelly A Wong, Angela Worth, Ross Martin, et al.
Antiviral Research|December 10, 2008
Development of a replicon-based phenotypic assay for assessing the drug susceptibilities of HCV NS3 protease genes from clinical isolatesXiaoping Qi, Andrew Bae, Shan Liu, et al.
Biomedical Chromatography : BMC|April 23, 2015
Simultaneous determination of ascaridole, p-cymene and α-terpinene in rat plasma after oral administration of Chenopodium ambrosioides L. by GC-MSXiaoqian Hu, Yang Chu, Gang Ma, et al.
Journal of Viral Hepatitis|April 23, 2019
In vitro resistance profile of hepatitis C virus NS5A inhibitor velpatasvir in genotypes 1 to 6Hadas Dvory-Sobol, Bin Han, Julia Lu, et al.
Journal of Clinical Microbiology|February 8, 2019
<i>In Vitro</i> Susceptibility of Hepatitis C Virus Genotype 1 through 6 Clinical Isolates to the Pangenotypic NS3/4A Inhibitor VoxilaprevirBin Han, Bandita Parhy, Julia Lu, et al.
The Lancet. Infectious Diseases|January 25, 2016
Ledipasvir-sofosbuvir in patients with hepatitis C virus genotype 5 infection: an open-label, multicentre, single-arm, phase 2 studyArmand Abergel, Tarik Asselah, Sophie Metivier, et al.
Antiviral Research|September 10, 2013
In vitro efficacy of approved and experimental antivirals against novel genotype 3 hepatitis C virus subgenomic repliconsMei Yu, Amoreena C Corsa, Simin Xu, et al.
Pageof 13